Database ID | Agent | Target | Cancer Type | Detail |
DB01036 | bevacizumab | Vascular endothelial growth factor | breast cancer | view |
DB01037 | bevacizumab | Vascular endothelial growth factor | breast cancer | view |
DB01038 | bevacizumab | Vascular endothelial growth factor | breast cancer | view |
DB01039 | bevacizumab | Vascular endothelial growth factor | breast cancer | view |
DB01040 | sorafenib | Vascular endothelial growth factor receptor 1 BRaf protooncogene serine/threonineprotein kinase Protooncogene tyrosineprotein kinase receptor ret | breast cancer | view |
DB01041 | sorafenib | Vascular endothelial growth factor receptor 1 BRaf protooncogene serine/threonineprotein kinase Protooncogene tyrosineprotein kinase receptor ret | breast cancer | view |
DB01042 | sorafenib | Vascular endothelial growth factor receptor 1 BRaf protooncogene serine/threonineprotein kinase Protooncogene tyrosineprotein kinase receptor ret | breast cancer | view |
DB01043 | sorafenib | Vascular endothelial growth factor receptor 1 BRaf protooncogene serine/threonineprotein kinase Protooncogene tyrosineprotein kinase receptor ret | breast cancer | view |
DB01044 | sorafenib | Vascular endothelial growth factor receptor 1 BRaf protooncogene serine/threonineprotein kinase Protooncogene tyrosineprotein kinase receptor ret | breast cancer | view |
DB01045 | olaparib | Poly [ADPribose] polymerase1 | breast cancer | view |
DB01046 | lapatinib | Epidermal growth factor receptor Receptor proteintyrosine kinase erbB2 | breast cancer | view |
DB01047 | lapatinib | Epidermal growth factor receptor Receptor proteintyrosine kinase erbB2 | breast cancer | view |
DB01048 | Trastuzumab Emtansine | human epidermal growth factor receptor 2 and microtubuleinhibitory | breast cancer | view |
DB01049 | lapatinib | Epidermal growth factor receptor Receptor proteintyrosine kinase erbB2 | breast cancer | view |
DB01050 | lapatinib | Epidermal growth factor receptor Receptor proteintyrosine kinase erbB2 | breast cancer | view |